Table 2.
Effect of treatments on femoral bone mineral density (BMD), bone mineral content (BMC), and BV/TV of the left femur.
| Treatment group (n = 10) |
Bone mineral density (BMD) (mg/cm2) |
Bone mineral content (BMC) (g) |
Bone volume (BV/TV) (%) |
|---|---|---|---|
| Sham | 192.0 ± 8.0b | 0.48 ± 0.4b | 35.5 ± 5.4b |
| OVX | 164.0 ± 6.7a | 0.37 ± 0.3a | 12.6 ± 3.3a |
| OVX + E2 | 185.0 ± 5.0b | 0.44 ± 0.5b | 28.7 ± 4.3b |
| OVX + BCA | 188.0 ± 8.6b | 0.48 ± 0.6b | 31.8 ± 4.5b |
BMD (mg/cm2) and BMC (g) were measured by Dual Energy X-Ray Absorptiometry. Values are expressed as means ± SD. Means within a column with different superscript letters are significantly different (P < 0.05, ANOVA and the Fisher test). a P < 0.05, when compared with the sham groups; b P < 0.05, when compared with the OVX group.